← Back to Clinical Trials
Recruiting NCT07362680

NCT07362680 Effects of Ultrasound-guided Recruitment Manoeuvres on Postoperative Pulmonary Complications in OSA Patients Undergoing Total Laparoscopic Hysterectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07362680
Status Recruiting
Phase —
Sponsor The First Affiliated Hospital of Xinxiang Medical College
Condition Total Laparoscopic Hysterectomy
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-05-02
Primary Completion 2026-08-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
the sustained inflation recruitment maneuverthe incremental PEEP recruitment maneuverthe Ultrasound-guided recruitment maneuver

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2025-05-02 with a primary completion date of 2026-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the lung-protective effects of ultrasound-guided lung recruitment maneuvers in patients with OSA undergoing total laparoscopic hysterectomy and to explore the efficacy of EELV measurement in assessing the effectiveness of these maneuvers.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years; * Scheduled for elective total laparoscopic hysterectomy; * American Society of Anesthesiologists (ASA) I to III; * BMI \> 28 kg/m²; * STOP-BANG score ≥ 3. Exclusion Criteria: * Abnormal findings on preoperative chest X-ray or CT, such as atelectasis, pneumothorax, thoracic deformity, pleural effusion, or neuromuscular diseases; * Pre-existing severe pulmonary diseases; * Severe cardiac arrhythmias or a history of cardiac surgery; * Allergy to any medications used in the study.

Frequently Asked Questions

Who can join the NCT07362680 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Total Laparoscopic Hysterectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07362680 currently recruiting?

Yes, NCT07362680 is actively recruiting participants. Visit ClinicalTrials.gov or contact The First Affiliated Hospital of Xinxiang Medical College to inquire about joining.

Where is the NCT07362680 trial being conducted?

This trial is being conducted at Xinxiang, China.

Who is sponsoring the NCT07362680 clinical trial?

NCT07362680 is sponsored by The First Affiliated Hospital of Xinxiang Medical College. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology